Ignite Creation Date:
2024-05-06 @ 3:42 PM
Last Modification Date:
2024-10-26 @ 1:54 PM
Study NCT ID:
NCT04722887
Status:
RECRUITING
Last Update Posted:
2024-06-06
First Post:
2021-01-20
Brief Title:
A Study to Evaluate Safety Tolerability and Pharmacokinetics of Two Different Doses of Alpha1-Proteinase Inhibitor Subcutaneous Human 15 in Participants With Alpha1-Antitrypsin Deficiency
Sponsor:
Grifols Therapeutics LLC
Organization:
Grifols Therapeutics LLC
Organization Data
Organization:
Grifols Therapeutics LLC
Class:
INDUSTRY
Study ID:
GC2008
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Grifols Therapeutics LLC
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None